Skip Navigation

Rheumatology 2005 44(Supplement 3):iii4; doi:10.1093/rheumatology/keh735
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Duhaut, P.
Right arrow Articles by Ducroix, J. P.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Duhaut, P.
Right arrow Articles by Ducroix, J. P.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?




Supplement Article

OP10. INCIDENCE OF CARDIOVASCULAR EVENTS IN BIOPSY-PROVEN AND BIOPSY-NEGATIVE GIANT CELL ARTERITIS: THE PROSPECTIVE, MULTICENTRIC DOUBLE COHORT GRACG STUDY

P. Duhaut1, L. Le Page1, S. Bosshard2, D. Seydoux3, H. Pellet4, J. C. Piette5 and J. P. Ducroix1

1 Department of Internal Medicine and RECIF, CHU Nord, Amiens, France, 2 Laboratory of Virology et 4 RECIF, Lyon-Grange-Blanche School of Medicine, Lyon, France, 3 Société de Secours Minière de la Loire, Saint-Etienne, France, 5 Department of Internal Medicine 2, Pitié-Salpêtrière Hospital, Paris, France

Background: Pre-existing atheromatous disease may be a risk factor for Giant Cell Arteritis (GCA). Also, coronary vasculitis, cerebro-vascular disease, and upper or lower limb arteritis may be related to GCA in some patients. Increased rates of cardiovascular events as compared with expected rates have been reported in Scandinavian populations. Our objective was to assess in a prospective, double cohort study, the relative risk of cardiovascular events in GCA patients compared with randomly selected, population based, sex- and age-matched controls included at the time of diagnosis of the cases.

Methods: 396 GCA patients (288 females, 108 males, 271 biopsy proven, and 125 biopsy negative cases) have been included on pre-defined criteria at the time of diagnosis, along with 290 controls. A follow-up questionnaire has been sent every 6 months to their physician, over a 5-year period. The 5-year relative risk has been adjusted according to Mantel-Haenszel, and interval confidence computed according to Greenland-Robins.

Results are given in the table.


View this table:
[in this window]
[in a new window]
 
 
Cumulative incidence of stroke is significantly increased in cases, but remains always lower than 3%/6 months. Incidence of angina pectoris is lower than 5% per year. There are no differences between cases and controls as regard myocardial infarction, transient cerebral attack, or lower limb arteriopathy.

Conclusion: Although overall mortality is similar in GCA patients and controls, incidence of stroke and angina pectoris is slightly increased in the former, and long-term anti-platelet therapy needs to be assessed.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.